Powered by


                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS







   Forum Archives





















   Primary Care






   Other Sections


   Research Tools

   Medical Tutorials

   Medical Software




Back to Drug index

Back to Anticholinergics

Ipratropium bromide


The FDA approved Xolair?, the first in a new class of asthma therapies that are bioengineered to target IgE.


tellfrnd.gif (30x26 -- 1330 bytes)send to a friend
prntfrnd.gif (30x26 -- 1309 bytes)printer friendly version

Asthma disease review



Pregnancy Category B

Drug classes


Mechanism of action

Anticholinergic, chemically related to atropine, which blocks vagally mediated reflexes by antagonizing the action of acetylcholine.


  1. Bronchodilator for maintenance treatment of bronchospasm associated with COPD


  1. Hypersensitivity to atropine or its
  2. Acute episodes of bronchospasm.

Use caution in the presence of narrow-angle glaucoma, prostatic hypertrophy, bladder neck obstruction, pregnancy, lactation.

advertisement.gif (61x7 -- 0 bytes)

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application

Adverse effects

  • CNS: Nervousness, dizziness, headache, fatigue, insomnia, blurred vision
  • GI: Nausea, GI distress, dry mouth
  • Respiratory: Cough, exacerbation of symptoms, hoarseness
  • Other: Palpitations, rash

 advertisement.gif (61x7 -- 0 bytes)



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright 2001-2012 DoctorsLounge. All rights reserved.